+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Radioembolization Therapy Market - Global Forecast 2026-2032- Product Image
Radioembolization Therapy Market - Global Forecast 2026-2032- Product Image
Sale

Radioembolization Therapy Market - Global Forecast 2026-2032

  • Report

  • 189 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6055349
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Radioembolization Therapy Market is projected to reach USD 1.21 Billion in 2026. It is expected to continue growing at a CAGR of 6.14%, reaching USD 1.75 Billion by 2032.

Radioembolization Therapy: Executive Overview

Radioembolization therapy is a locoregional treatment that delivers radioactive microspheres through the hepatic arterial system, concentrating radiation in targeted liver tumors while limiting exposure to surrounding tissue. Its clinical role is most established in selected primary and metastatic liver cancers, particularly when surgery or ablation is unsuitable. Adoption depends on multidisciplinary assessment, vascular mapping, dosimetry, patient selection, and access to interventional radiology and nuclear medicine expertise.

Clinical Integration Is Reshaping Radioembolization Practice

The field is shifting from procedure-centered delivery toward integrated care pathways that connect diagnosis, tumor-board review, treatment planning, dosimetry, follow-up imaging, and management of liver function. Greater emphasis on personalized particle selection, segmental or lobar treatment strategies, and combination approaches is encouraging clinicians to match therapy intensity and delivery technique with tumor burden, anatomy, and hepatic reserve. Evidence generation is also moving toward more standardized endpoints and comparative studies across treatment settings.

Artificial Intelligence Is Strengthening Planning and Follow-Up

Artificial intelligence can support radioembolization through automated image segmentation, tumor and liver-volume assessment, vascular anatomy analysis, treatment planning, dosimetry, and longitudinal response evaluation. These tools may improve reproducibility and reduce time spent on complex imaging workflows, while decision-support systems can help identify patients who require additional review. However, reliable deployment requires representative clinical data, transparent validation, human oversight, cybersecurity controls, and clear accountability for treatment decisions.

Regional Insights: Uneven Access Shapes Adoption

North America benefits from established interventional oncology infrastructure and multidisciplinary cancer programs, although reimbursement, referral pathways, and workforce availability influence access. Europe combines advanced clinical capabilities with differing national assessment and funding processes. Asia-Pacific shows substantial clinical potential alongside wide variation in hospital capacity, regulatory pathways, and specialist training. Latin America is progressing through leading tertiary centers but faces concentration of expertise and equipment in major cities. The Middle East is expanding specialized oncology services, with access shaped by national health strategies and referral networks. Africa remains highly heterogeneous, with adoption constrained in many settings by imaging, radiopharmacy, specialist, and financing limitations.

Group Insights: Health-System Coordination Is Central

ASEAN markets reflect varied levels of specialist capacity, cross-border referral, and regulatory maturity, making regional training and standardized protocols especially relevant. BRICS countries encompass large and diverse patient populations but differ considerably in infrastructure, reimbursement, and domestic manufacturing capability. The European Union benefits from clinical collaboration and shared scientific exchange, while national funding decisions remain important. G7 systems generally have strong research and hospital capabilities, with attention focused on evidence quality, value assessment, and equitable access. GCC countries are investing in advanced cancer services and centralized expertise. NATO members span mature and emerging healthcare systems, creating opportunities for shared standards while preserving national regulatory requirements.

Country Insights: Capability and Policy Drive Differentiation

The United States and Canada have developed interventional oncology networks, with access influenced by specialist distribution, coverage policy, and referral coordination. Germany, France, Italy, Spain, and the United Kingdom have established European expertise, but treatment availability and commissioning pathways differ by country. Australia and Japan combine sophisticated clinical infrastructure with geographically uneven access. China and India are expanding specialist capacity across major centers, while implementation varies between urban and less-served regions. South Korea has strong tertiary-care capabilities and technology adoption. Brazil, Mexico, and Russia show meaningful activity concentrated in specialized institutions, with affordability, regional access, and health-system organization remaining important considerations.

Action Priorities for Radioembolization Leaders

Industry leaders should strengthen multidisciplinary referral pathways, invest in training for interventional radiology, nuclear medicine, medical oncology, and medical physics teams, and standardize patient-selection and follow-up protocols. Evidence strategies should prioritize clinically meaningful outcomes, transparent dosimetry methods, real-world safety monitoring, and comparisons across relevant treatment lines. Organizations should also build resilient isotope and microsphere logistics, support interoperable imaging workflows, validate AI tools prospectively, and design access programs suited to regional infrastructure and reimbursement conditions.

Research Methodology: Evidence-Centered Market Assessment

This executive summary uses a structured review of the radioembolization therapy landscape, focusing on clinical application, care delivery, enabling technologies, regional conditions, health-system groupings, and country-level implementation factors. Insights are synthesized from established clinical practice patterns, healthcare infrastructure considerations, regulatory and reimbursement themes, and documented technology trends. The assessment intentionally excludes market estimates, market sizing, market shares, forecasts, and company-specific analysis; conclusions should be interpreted in light of differences in evidence quality and local treatment availability.

Conclusion: Sustainable Adoption Requires Integrated Capability

Radioembolization therapy is advancing as part of a broader movement toward personalized, image-guided and multidisciplinary cancer care. Its continued clinical value will depend not only on procedural effectiveness but also on appropriate selection, consistent dosimetry, coordinated follow-up, trained teams, reliable supply chains, and equitable access. Artificial intelligence can enhance these foundations, but it should complement-not replace-clinical judgment, prospective validation, and accountable governance.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Radioembolization Therapy Market, by Component
7.1. Introduction
7.2. Catheters
7.3. Nuclear Medicine Equipment
7.4. Radioactive Microspheres
7.5. X-Ray Equipment
8. Radioembolization Therapy Market, by Treatment Category
8.1. Introduction
8.2. Curative
8.3. Palliative
9. Radioembolization Therapy Market, by Tumor Type
9.1. Introduction
9.2. Metastatic Liver Cancer
9.3. Primary Liver Cancer
10. Radioembolization Therapy Market, by Application Procedure
10.1. Introduction
10.2. Liver Tumour
10.3. Lobar Therapy
10.4. Segmental Therapy
11. Radioembolization Therapy Market, by End-User
11.1. Introduction
11.2. Ambulatory Surgical Centers
11.3. Cancer Research Institutes
11.4. Hospitals
12. Radioembolization Therapy Market, by Region
12.1. Introduction
12.2. Asia-Pacific
12.3. North America
12.4. Latin America
12.5. Europe
12.6. Middle East
12.7. Africa
13. Radioembolization Therapy Market, by Group
13.1. Introduction
13.2. ASEAN
13.3. GCC
13.4. European Union
13.5. BRICS
13.6. G7
13.7. NATO
14. Radioembolization Therapy Market, by Country
14.1. Introduction
14.2. United States
14.3. Germany
14.4. China
14.5. United Kingdom
14.6. India
14.7. Japan
14.8. Russia
14.9. Brazil
14.10. Canada
14.11. Italy
14.12. Mexico
14.13. France
14.14. Spain
14.15. Australia
14.16. South Korea
15. Competitive Landscape
15.1. Market Share Analysis, 2025
15.2. Market Concentration Analysis, 2025
15.2.1. Concentration Ratio (CR)
15.2.2. Herfindahl Hirschman Index (HHI)
15.3. Recent Developments & Impact Analysis, 2025
15.4. Product Portfolio Analysis, 2025
15.5. Benchmarking Analysis, 2025
16. Company Profiles
16.1. Bayer AG
16.2. Becton Dickinson & Company
16.3. Boston Scientific Corporation
16.4. Cook Medical Inc.
16.5. Elekta AB
16.6. Fortis Healthcare Limited
16.7. Hamilton Health Sciences
16.8. Mayo Clinic Health System
16.9. Medtronic plc
16.10. Merit Medical Systems, Inc.
16.11. Nordion Inc.
16.12. Northwestern Memorial HealthCare.
16.13. Radiological Society of North America, Inc.
16.14. Siemens AG
16.15. Sirtex Medical Pty Ltd
16.16. Stryker Corporation
16.17. Terumo Corporation
16.18. United HealthCare Services, Inc
17. Key Experts
LIST OF FIGURES
FIGURE 1. Global Radioembolization Therapy Market, Years Considered for the Study
FIGURE 2. Global Radioembolization Therapy Market, Research Design
FIGURE 3. Global Radioembolization Therapy Market, Research Framework
FIGURE 4. Global Radioembolization Therapy Market, Data Triangulation
FIGURE 5. Global Radioembolization Therapy Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Radioembolization Therapy Market Size, by Component, 2025 vs 2032 (%)
FIGURE 7. Global Radioembolization Therapy Market Size, by Component, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Radioembolization Therapy Market Size, by Treatment Category, 2025 vs 2032 (%)
FIGURE 9. Global Radioembolization Therapy Market Size, by Treatment Category, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Radioembolization Therapy Market Size, by Tumor Type, 2025 vs 2032 (%)
FIGURE 11. Global Radioembolization Therapy Market Size, by Tumor Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Radioembolization Therapy Market Size, by Application Procedure, 2025 vs 2032 (%)
FIGURE 13. Global Radioembolization Therapy Market Size, by Application Procedure, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Radioembolization Therapy Market Size, by End-User, 2025 vs 2032 (%)
FIGURE 15. Global Radioembolization Therapy Market Size, by End-User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Radioembolization Therapy Market Size, by Region, 2025 vs 2032 (%)
FIGURE 17. Global Radioembolization Therapy Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Radioembolization Therapy Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Radioembolization Therapy Market Size, by Country, 2025 vs 2032 (%)
FIGURE 20. Global Radioembolization Therapy Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global Radioembolization Therapy Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Radioembolization Therapy Market Segmentation & Coverage
TABLE 2. Global Radioembolization Therapy Market Size, 2017-2032 (USD Million)
TABLE 3. Global Radioembolization Therapy Market Size, by Component, 2017-2032 (USD Million)
TABLE 4. Global Catheters Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Catheters Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Catheters Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Nuclear Medicine Equipment Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Nuclear Medicine Equipment Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Nuclear Medicine Equipment Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Radioactive Microspheres Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Radioactive Microspheres Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Radioactive Microspheres Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global X-Ray Equipment Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global X-Ray Equipment Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global X-Ray Equipment Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Radioembolization Therapy Market Size, by Treatment Category, 2017-2032 (USD Million)
TABLE 17. Global Curative Market Size, by Region, 2017-2032 (USD Million)
TABLE 18. Global Curative Market Size, by Group, 2017-2032 (USD Million)
TABLE 19. Global Curative Market Size, by Country, 2017-2032 (USD Million)
TABLE 20. Global Palliative Market Size, by Region, 2017-2032 (USD Million)
TABLE 21. Global Palliative Market Size, by Group, 2017-2032 (USD Million)
TABLE 22. Global Palliative Market Size, by Country, 2017-2032 (USD Million)
TABLE 23. Global Radioembolization Therapy Market Size, by Tumor Type, 2017-2032 (USD Million)
TABLE 24. Global Metastatic Liver Cancer Market Size, by Region, 2017-2032 (USD Million)
TABLE 25. Global Metastatic Liver Cancer Market Size, by Group, 2017-2032 (USD Million)
TABLE 26. Global Metastatic Liver Cancer Market Size, by Country, 2017-2032 (USD Million)
TABLE 27. Global Primary Liver Cancer Market Size, by Region, 2017-2032 (USD Million)
TABLE 28. Global Primary Liver Cancer Market Size, by Group, 2017-2032 (USD Million)
TABLE 29. Global Primary Liver Cancer Market Size, by Country, 2017-2032 (USD Million)
TABLE 30. Global Radioembolization Therapy Market Size, by Application Procedure, 2017-2032 (USD Million)
TABLE 31. Global Liver Tumour Market Size, by Region, 2017-2032 (USD Million)
TABLE 32. Global Liver Tumour Market Size, by Group, 2017-2032 (USD Million)
TABLE 33. Global Liver Tumour Market Size, by Country, 2017-2032 (USD Million)
TABLE 34. Global Lobar Therapy Market Size, by Region, 2017-2032 (USD Million)
TABLE 35. Global Lobar Therapy Market Size, by Group, 2017-2032 (USD Million)
TABLE 36. Global Lobar Therapy Market Size, by Country, 2017-2032 (USD Million)
TABLE 37. Global Segmental Therapy Market Size, by Region, 2017-2032 (USD Million)
TABLE 38. Global Segmental Therapy Market Size, by Group, 2017-2032 (USD Million)
TABLE 39. Global Segmental Therapy Market Size, by Country, 2017-2032 (USD Million)
TABLE 40. Global Radioembolization Therapy Market Size, by End-User, 2017-2032 (USD Million)
TABLE 41. Global Ambulatory Surgical Centers Market Size, by Region, 2017-2032 (USD Million)
TABLE 42. Global Ambulatory Surgical Centers Market Size, by Group, 2017-2032 (USD Million)
TABLE 43. Global Ambulatory Surgical Centers Market Size, by Country, 2017-2032 (USD Million)
TABLE 44. Global Cancer Research Institutes Market Size, by Region, 2017-2032 (USD Million)
TABLE 45. Global Cancer Research Institutes Market Size, by Group, 2017-2032 (USD Million)
TABLE 46. Global Cancer Research Institutes Market Size, by Country, 2017-2032 (USD Million)
TABLE 47. Global Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 48. Global Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 49. Global Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 50. Global Radioembolization Therapy Market Size, by Region, 2017-2032 (USD Million)
TABLE 51. Asia-Pacific Radioembolization Therapy Market Size, by Region, 2017-2032 (USD Million)
TABLE 52. Asia-Pacific Radioembolization Therapy Market Size, by Component, 2017-2032 (USD Million)
TABLE 53. Asia-Pacific Radioembolization Therapy Market Size, by Treatment Category, 2017-2032 (USD Million)
TABLE 54. Asia-Pacific Radioembolization Therapy Market Size, by Tumor Type, 2017-2032 (USD Million)
TABLE 55. Asia-Pacific Radioembolization Therapy Market Size, by Application Procedure, 2017-2032 (USD Million)
TABLE 56. Asia-Pacific Radioembolization Therapy Market Size, by End-User, 2017-2032 (USD Million)
TABLE 57. North America Radioembolization Therapy Market Size, by Region, 2017-2032 (USD Million)
TABLE 58. North America Radioembolization Therapy Market Size, by Component, 2017-2032 (USD Million)
TABLE 59. North America Radioembolization Therapy Market Size, by Treatment Category, 2017-2032 (USD Million)
TABLE 60. North America Radioembolization Therapy Market Size, by Tumor Type, 2017-2032 (USD Million)
TABLE 61. North America Radioembolization Therapy Market Size, by Application Procedure, 2017-2032 (USD Million)
TABLE 62. North America Radioembolization Therapy Market Size, by End-User, 2017-2032 (USD Million)
TABLE 63. Latin America Radioembolization Therapy Market Size, by Region, 2017-2032 (USD Million)
TABLE 64. Latin America Radioembolization Therapy Market Size, by Component, 2017-2032 (USD Million)
TABLE 65. Latin America Radioembolization Therapy Market Size, by Treatment Category, 2017-2032 (USD Million)
TABLE 66. Latin America Radioembolization Therapy Market Size, by Tumor Type, 2017-2032 (USD Million)
TABLE 67. Latin America Radioembolization Therapy Market Size, by Application Procedure, 2017-2032 (USD Million)
TABLE 68. Latin America Radioembolization Therapy Market Size, by End-User, 2017-2032 (USD Million)
TABLE 69. Europe Radioembolization Therapy Market Size, by Region, 2017-2032 (USD Million)
TABLE 70. Europe Radioembolization Therapy Market Size, by Component, 2017-2032 (USD Million)
TABLE 71. Europe Radioembolization Therapy Market Size, by Treatment Category, 2017-2032 (USD Million)
TABLE 72. Europe Radioembolization Therapy Market Size, by Tumor Type, 2017-2032 (USD Million)
TABLE 73. Europe Radioembolization Therapy Market Size, by Application Procedure, 2017-2032 (USD Million)
TABLE 74. Europe Radioembolization Therapy Market Size, by End-User, 2017-2032 (USD Million)
TABLE 75. Middle East Radioembolization Therapy Market Size, by Region, 2017-2032 (USD Million)
TABLE 76. Middle East Radioembolization Therapy Market Size, by Component, 2017-2032 (USD Million)
TABLE 77. Middle East Radioembolization Therapy Market Size, by Treatment Category, 2017-2032 (USD Million)
TABLE 78. Middle East Radioembolization Therapy Market Size, by Tumor Type, 2017-2032 (USD Million)
TABLE 79. Middle East Radioembolization Therapy Market Size, by Application Procedure, 2017-2032 (USD Million)
TABLE 80. Middle East Radioembolization Therapy Market Size, by End-User, 2017-2032 (USD Million)
TABLE 81. Africa Radioembolization Therapy Market Size, by Region, 2017-2032 (USD Million)
TABLE 82. Africa Radioembolization Therapy Market Size, by Component, 2017-2032 (USD Million)
TABLE 83. Africa Radioembolization Therapy Market Size, by Treatment Category, 2017-2032 (USD Million)
TABLE 84. Africa Radioembolization Therapy Market Size, by Tumor Type, 2017-2032 (USD Million)
TABLE 85. Africa Radioembolization Therapy Market Size, by Application Procedure, 2017-2032 (USD Million)
TABLE 86. Africa Radioembolization Therapy Market Size, by End-User, 2017-2032 (USD Million)
TABLE 87. Global Radioembolization Therapy Market Size, by Group, 2017-2032 (USD Million)
TABLE 88. ASEAN Radioembolization Therapy Market Size, by Group, 2017-2032 (USD Million)
TABLE 89. ASEAN Radioembolization Therapy Market Size, by Component, 2017-2032 (USD Million)
TABLE 90. ASEAN Radioembolization Therapy Market Size, by Treatment Category, 2017-2032 (USD Million)
TABLE 91. ASEAN Radioembolization Therapy Market Size, by Tumor Type, 2017-2032 (USD Million)
TABLE 92. ASEAN Radioembolization Therapy Market Size, by Application Procedure, 2017-2032 (USD Million)
TABLE 93. ASEAN Radioembolization Therapy Market Size, by End-User, 2017-2032 (USD Million)
TABLE 94. GCC Radioembolization Therapy Market Size, by Group, 2017-2032 (USD Million)
TABLE 95. GCC Radioembolization Therapy Market Size, by Component, 2017-2032 (USD Million)
TABLE 96. GCC Radioembolization Therapy Market Size, by Treatment Category, 2017-2032 (USD Million)
TABLE 97. GCC Radioembolization Therapy Market Size, by Tumor Type, 2017-2032 (USD Million)
TABLE 98. GCC Radioembolization Therapy Market Size, by Application Procedure, 2017-2032 (USD Million)
TABLE 99. GCC Radioembolization Therapy Market Size, by End-User, 2017-2032 (USD Million)
TABLE 100. European Union Radioembolization Therapy Market Size, by Group, 2017-2032 (USD Million)
TABLE 101. European Union Radioembolization Therapy Market Size, by Component, 2017-2032 (USD Million)
TABLE 102. European Union Radioembolization Therapy Market Size, by Treatment Category, 2017-2032 (USD Million)
TABLE 103. European Union Radioembolization Therapy Market Size, by Tumor Type, 2017-2032 (USD Million)
TABLE 104. European Union Radioembolization Therapy Market Size, by Application Procedure, 2017-2032 (USD Million)
TABLE 105. European Union Radioembolization Therapy Market Size, by End-User, 2017-2032 (USD Million)
TABLE 106. BRICS Radioembolization Therapy Market Size, by Group, 2017-2032 (USD Million)
TABLE 107. BRICS Radioembolization Therapy Market Size, by Component, 2017-2032 (USD Million)
TABLE 108. BRICS Radioembolization Therapy Market Size, by Treatment Category, 2017-2032 (USD Million)
TABLE 109. BRICS Radioembolization Therapy Market Size, by Tumor Type, 2017-2032 (USD Million)
TABLE 110. BRICS Radioembolization Therapy Market Size, by Application Procedure, 2017-2032 (USD Million)
TABLE 111. BRICS Radioembolization Therapy Market Size, by End-User, 2017-2032 (USD Million)
TABLE 112. G7 Radioembolization Therapy Market Size, by Group, 2017-2032 (USD Million)
TABLE 113. G7 Radioembolization Therapy Market Size, by Component, 2017-2032 (USD Million)
TABLE 114. G7 Radioembolization Therapy Market Size, by Treatment Category, 2017-2032 (USD Million)
TABLE 115. G7 Radioembolization Therapy Market Size, by Tumor Type, 2017-2032 (USD Million)
TABLE 116. G7 Radioembolization Therapy Market Size, by Application Procedure, 2017-2032 (USD Million)
TABLE 117. G7 Radioembolization Therapy Market Size, by End-User, 2017-2032 (USD Million)
TABLE 118. NATO Radioembolization Therapy Market Size, by Group, 2017-2032 (USD Million)
TABLE 119. NATO Radioembolization Therapy Market Size, by Component, 2017-2032 (USD Million)
TABLE 120. NATO Radioembolization Therapy Market Size, by Treatment Category, 2017-2032 (USD Million)
TABLE 121. NATO Radioembolization Therapy Market Size, by Tumor Type, 2017-2032 (USD Million)
TABLE 122. NATO Radioembolization Therapy Market Size, by Application Procedure, 2017-2032 (USD Million)
TABLE 123. NATO Radioembolization Therapy Market Size, by End-User, 2017-2032 (USD Million)
TABLE 124. Global Radioembolization Therapy Market Size, by Country, 2017-2032 (USD Million)
TABLE 125. United States Radioembolization Therapy Market Size, 2017-2032 (USD Million)
TABLE 126. United States Radioembolization Therapy Market Size, by Component, 2017-2032 (USD Million)
TABLE 127. United States Radioembolization Therapy Market Size, by Treatment Category, 2017-2032 (USD Million)
TABLE 128. United States Radioembolization Therapy Market Size, by Tumor Type, 2017-2032 (USD Million)
TABLE 129. United States Radioembolization Therapy Market Size, by Application Procedure, 2017-2032 (USD Million)
TABLE 130. United States Radioembolization Therapy Market Size, by End-User, 2017-2032 (USD Million)
TABLE 131. Germany Radioembolization Therapy Market Size, 2017-2032 (USD Million)
TABLE 132. Germany Radioembolization Therapy Market Size, by Component, 2017-2032 (USD Million)
TABLE 133. Germany Radioembolization Therapy Market Size, by Treatment Category, 2017-2032 (USD Million)
TABLE 134. Germany Radioembolization Therapy Market Size, by Tumor Type, 2017-2032 (USD Million)
TABLE 135. Germany Radioembolization Therapy Market Size, by Application Procedure, 2017-2032 (USD Million)
TABLE 136. Germany Radioembolization Therapy Market Size, by End-User, 2017-2032 (USD Million)
TABLE 137. China Radioembolization Therapy Market Size, 2017-2032 (USD Million)
TABLE 138. China Radioembolization Therapy Market Size, by Component, 2017-2032 (USD Million)
TABLE 139. China Radioembolization Therapy Market Size, by Treatment Category, 2017-2032 (USD Million)
TABLE 140. China Radioembolization Therapy Market Size, by Tumor Type, 2017-2032 (USD Million)
TABLE 141. China Radioembolization Therapy Market Size, by Application Procedure, 2017-2032 (USD Million)
TABLE 142. China Radioembolization Therapy Market Size, by End-User, 2017-2032 (USD Million)
TABLE 143. United Kingdom Radioembolization Therapy Market Size, 2017-2032 (USD Million)
TABLE 144. United Kingdom Radioembolization Therapy Market Size, by Component, 2017-2032 (USD Million)
TABLE 145. United Kingdom Radioembolization Therapy Market Size, by Treatment Category, 2017-2032 (USD Million)
TABLE 146. United Kingdom Radioembolization Therapy Market Size, by Tumor Type, 2017-2032 (USD Million)
TABLE 147. United Kingdom Radioembolization Therapy Market Size, by Application Procedure, 2017-2032 (USD Million)
TABLE 148. United Kingdom Radioembolization Therapy Market Size, by End-User, 2017-2032 (USD Million)
TABLE 149. India Radioembolization Therapy Market Size, 2017-2032 (USD Million)
TABLE 150. India Radioembolization Therapy Market Size, by Component, 2017-2032 (USD Million)
TABLE 151. India Radioembolization Therapy Market Size, by Treatment Category, 2017-2032 (USD Million)
TABLE 152. India Radioembolization Therapy Market Size, by Tumor Type, 2017-2032 (USD Million)
TABLE 153. India Radioembolization Therapy Market Size, by Application Procedure, 2017-2032 (USD Million)
TABLE 154. India Radioembolization Therapy Market Size, by End-User, 2017-2032 (USD Million)
TABLE 155. Japan Radioembolization Therapy Market Size, 2017-2032 (USD Million)
TABLE 156. Japan Radioembolization Therapy Market Size, by Component, 2017-2032 (USD Million)
TABLE 157. Japan Radioembolization Therapy Market Size, by Treatment Category, 2017-2032 (USD Million)
TABLE 158. Japan Radioembolization Therapy Market Size, by Tumor Type, 2017-2032 (USD Million)
TABLE 159. Japan Radioembolization Therapy Market Size, by Application Procedure, 2017-2032 (USD Million)
TABLE 160. Japan Radioembolization Therapy Market Size, by End-User, 2017-2032 (USD Million)
TABLE 161. Russia Radioembolization Therapy Market Size, 2017-2032 (USD Million)
TABLE 162. Russia Radioembolization Therapy Market Size, by Component, 2017-2032 (USD Million)
TABLE 163. Russia Radioembolization Therapy Market Size, by Treatment Category, 2017-2032 (USD Million)
TABLE 164. Russia Radioembolization Therapy Market Size, by Tumor Type, 2017-2032 (USD Million)
TABLE 165. Russia Radioembolization Therapy Market Size, by Application Procedure, 2017-2032 (USD Million)
TABLE 166. Russia Radioembolization Therapy Market Size, by End-User, 2017-2032 (USD Million)
TABLE 167. Brazil Radioembolization Therapy Market Size, 2017-2032 (USD Million)
TABLE 168. Brazil Radioembolization Therapy Market Size, by Component, 2017-2032 (USD Million)
TABLE 169. Brazil Radioembolization Therapy Market Size, by Treatment Category, 2017-2032 (USD Million)
TABLE 170. Brazil Radioembolization Therapy Market Size, by Tumor Type, 2017-2032 (USD Million)
TABLE 171. Brazil Radioembolization Therapy Market Size, by Application Procedure, 2017-2032 (USD Million)
TABLE 172. Brazil Radioembolization Therapy Market Size, by End-User, 2017-2032 (USD Million)
TABLE 173. Canada Radioembolization Therapy Market Size, 2017-2032 (USD Million)
TABLE 174. Canada Radioembolization Therapy Market Size, by Component, 2017-2032 (USD Million)
TABLE 175. Canada Radioembolization Therapy Market Size, by Treatment Category, 2017-2032 (USD Million)
TABLE 176. Canada Radioembolization Therapy Market Size, by Tumor Type, 2017-2032 (USD Million)
TABLE 177. Canada Radioembolization Therapy Market Size, by Application Procedure, 2017-2032 (USD Million)
TABLE 178. Canada Radioembolization Therapy Market Size, by End-User, 2017-2032 (USD Million)
TABLE 179. Italy Radioembolization Therapy Market Size, 2017-2032 (USD Million)
TABLE 180. Italy Radioembolization Therapy Market Size, by Component, 2017-2032 (USD Million)
TABLE 181. Italy Radioembolization Therapy Market Size, by Treatment Category, 2017-2032 (USD Million)
TABLE 182. Italy Radioembolization Therapy Market Size, by Tumor Type, 2017-2032 (USD Million)
TABLE 183. Italy Radioembolization Therapy Market Size, by Application Procedure, 2017-2032 (USD Million)
TABLE 184. Italy Radioembolization Therapy Market Size, by End-User, 2017-2032 (USD Million)
TABLE 185. Mexico Radioembolization Therapy Market Size, 2017-2032 (USD Million)
TABLE 186. Mexico Radioembolization Therapy Market Size, by Component, 2017-2032 (USD Million)
TABLE 187. Mexico Radioembolization Therapy Market Size, by Treatment Category, 2017-2032 (USD Million)
TABLE 188. Mexico Radioembolization Therapy Market Size, by Tumor Type, 2017-2032 (USD Million)
TABLE 189. Mexico Radioembolization Therapy Market Size, by Application Procedure, 2017-2032 (USD Million)
TABLE 190. Mexico Radioembolization Therapy Market Size, by End-User, 2017-2032 (USD Million)
TABLE 191. France Radioembolization Therapy Market Size, 2017-2032 (USD Million)
TABLE 192. France Radioembolization Therapy Market Size, by Component, 2017-2032 (USD Million)
TABLE 193. France Radioembolization Therapy Market Size, by Treatment Category, 2017-2032 (USD Million)
TABLE 194. France Radioembolization Therapy Market Size, by Tumor Type, 2017-2032 (USD Million)
TABLE 195. France Radioembolization Therapy Market Size, by Application Procedure, 2017-2032 (USD Million)
TABLE 196. France Radioembolization Therapy Market Size, by End-User, 2017-2032 (USD Million)
TABLE 197. Spain Radioembolization Therapy Market Size, 2017-2032 (USD Million)
TABLE 198. Spain Radioembolization Therapy Market Size, by Component, 2017-2032 (USD Million)
TABLE 199. Spain Radioembolization Therapy Market Size, by Treatment Category, 2017-2032 (USD Million)
TABLE 200. Spain Radioembolization Therapy Market Size, by Tumor Type, 2017-2032 (USD Million)
TABLE 201. Spain Radioembolization Therapy Market Size, by Application Procedure, 2017-2032 (USD Million)
TABLE 202. Spain Radioembolization Therapy Market Size, by End-User, 2017-2032 (USD Million)
TABLE 203. Australia Radioembolization Therapy Market Size, 2017-2032 (USD Million)
TABLE 204. Australia Radioembolization Therapy Market Size, by Component, 2017-2032 (USD Million)
TABLE 205. Australia Radioembolization Therapy Market Size, by Treatment Category, 2017-2032 (USD Million)
TABLE 206. Australia Radioembolization Therapy Market Size, by Tumor Type, 2017-2032 (USD Million)
TABLE 207. Australia Radioembolization Therapy Market Size, by Application Procedure, 2017-2032 (USD Million)
TABLE 208. Australia Radioembolization Therapy Market Size, by End-User, 2017-2032 (USD Million)
TABLE 209. South Korea Radioembolization Therapy Market Size, 2017-2032 (USD Million)
TABLE 210. South Korea Radioembolization Therapy Market Size, by Component, 2017-2032 (USD Million)
TABLE 211. South Korea Radioembolization Therapy Market Size, by Treatment Category, 2017-2032 (USD Million)
TABLE 212. South Korea Radioembolization Therapy Market Size, by Tumor Type, 2017-2032 (USD Million)
TABLE 213. South Korea Radioembolization Therapy Market Size, by Application Procedure, 2017-2032 (USD Million)
TABLE 214. South Korea Radioembolization Therapy Market Size, by End-User, 2017-2032 (USD Million)
TABLE 215. Global Radioembolization Therapy Market Share, by Key Player, 2025
TABLE 216. Global Radioembolization Therapy Market, Key Experts

Companies Mentioned

  • Bayer AG
  • Becton Dickinson & Company
  • Boston Scientific Corporation
  • Cook Medical Inc.
  • Elekta AB
  • Fortis Healthcare Limited
  • Hamilton Health Sciences
  • Mayo Clinic Health System
  • Medtronic plc
  • Merit Medical Systems, Inc.
  • Nordion Inc.
  • Northwestern Memorial HealthCare.
  • Radiological Society of North America, Inc.
  • Siemens AG
  • Sirtex Medical Pty Ltd
  • Stryker Corporation
  • Terumo Corporation
  • United HealthCare Services, Inc

Related Topics

Related Reports

Pharmaceuticals - Enterprise ICT - Product Image

Pharmaceuticals - Enterprise ICT

  • Report
  • 54 Pages
  • Global
From
U.S. Pharmaceutical Market, By Region, By Competition, Opportunities & Forecast, 2020-2030F - Product Image

U.S. Pharmaceutical Market, By Region, By Competition, Opportunities & Forecast, 2020-2030F

  • Report
  • 85 Pages
  • United States
From
Pharmaceuticals North America (NAFTA) Industry Guide 2019-2028 - Product Image

Pharmaceuticals North America (NAFTA) Industry Guide 2019-2028

  • Report
  • 286 Pages
  • North America
From
Pharmaceutical Glycerine Market - Global Forecast 2026-2032 - Product Image

Pharmaceutical Glycerine Market - Global Forecast 2026-2032

  • Report
  • 181 Pages
  • Global
From
Interventional Oncology Market - Global Forecast 2026-2032 - Product Image

Interventional Oncology Market - Global Forecast 2026-2032

  • Report
  • 186 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.